JP2023533037A5 - - Google Patents
Info
- Publication number
- JP2023533037A5 JP2023533037A5 JP2023501220A JP2023501220A JP2023533037A5 JP 2023533037 A5 JP2023533037 A5 JP 2023533037A5 JP 2023501220 A JP2023501220 A JP 2023501220A JP 2023501220 A JP2023501220 A JP 2023501220A JP 2023533037 A5 JP2023533037 A5 JP 2023533037A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- hydrogen
- halo
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063049838P | 2020-07-09 | 2020-07-09 | |
| US63/049,838 | 2020-07-09 | ||
| PCT/US2021/040798 WO2022011084A1 (en) | 2020-07-09 | 2021-07-08 | Oxopyrrolidine fpr2 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533037A JP2023533037A (ja) | 2023-08-01 |
| JP2023533037A5 true JP2023533037A5 (https=) | 2024-07-12 |
| JP7771157B2 JP7771157B2 (ja) | 2025-11-17 |
Family
ID=77207241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501220A Active JP7771157B2 (ja) | 2020-07-09 | 2021-07-08 | オキソピロリジン ｆｐｒ２アゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230348426A1 (https=) |
| EP (1) | EP4178946A1 (https=) |
| JP (1) | JP7771157B2 (https=) |
| KR (1) | KR20230038515A (https=) |
| CN (1) | CN116034104B (https=) |
| AR (1) | AR122912A1 (https=) |
| TW (1) | TW202216664A (https=) |
| WO (1) | WO2022011084A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7802765B2 (ja) | 2020-08-12 | 2026-01-20 | ブリストル－マイヤーズ スクイブ カンパニー | オキソピロリジン尿素ｆｐｒ２アゴニスト |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2752733T3 (es) * | 2013-11-28 | 2020-04-06 | Kyorin Seiyaku Kk | Derivados de urea deuterados o marcados isotópicamente o sales farmacológicamente aceptables de los mismos útiles como agonistas de FPRL-1 |
| WO2018227067A1 (en) * | 2017-06-09 | 2018-12-13 | Bristol-Myers Squibb Company | Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists |
| US10676431B2 (en) * | 2018-03-05 | 2020-06-09 | Bristol-Myers Squibb Company | Phenylpyrrolidinone formyl peptide 2 receptor agonists |
| AR114383A1 (es) * | 2018-03-09 | 2020-08-26 | Gruenenthal Gmbh | Piperidinas o piperidonas sustituidas con urea y fenilo |
| EP3880655A1 (en) * | 2018-11-16 | 2021-09-22 | Bristol-Myers Squibb Company | Synthetic processes for the production of 1-((3s,4r)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-3-phenylurea |
| CN113166134B (zh) * | 2018-11-26 | 2024-06-14 | 百时美施贵宝公司 | 作为甲酰肽2受体激动剂的吡咯烷酮衍生物 |
-
2021
- 2021-07-08 JP JP2023501220A patent/JP7771157B2/ja active Active
- 2021-07-08 WO PCT/US2021/040798 patent/WO2022011084A1/en not_active Ceased
- 2021-07-08 AR ARP210101919A patent/AR122912A1/es not_active Application Discontinuation
- 2021-07-08 KR KR1020237004527A patent/KR20230038515A/ko active Pending
- 2021-07-08 CN CN202180054243.1A patent/CN116034104B/zh active Active
- 2021-07-08 TW TW110125158A patent/TW202216664A/zh unknown
- 2021-07-08 US US18/004,731 patent/US20230348426A1/en active Pending
- 2021-07-08 EP EP21749925.0A patent/EP4178946A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024050527A5 (https=) | ||
| RU2007124681A (ru) | Производные тетрагидропирана в качестве противодиабетических средств | |
| FI89356B (fi) | Foerfarande foer framstaellnig av blodsockerhalten saenkande samt atherosklerosis hindrande tiazolidindioner | |
| JP2024540163A5 (https=) | ||
| JP2023538408A5 (https=) | ||
| JP2023540609A5 (https=) | ||
| JP2021535174A5 (https=) | ||
| JP2025509281A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2022544714A5 (https=) | ||
| US20120165288A1 (en) | Azapeptide derivatives | |
| JP2021535177A5 (https=) | ||
| JP2012530703A5 (https=) | ||
| JP2023544476A5 (https=) | ||
| JP2024540164A5 (https=) | ||
| JP2024513227A5 (https=) | ||
| JP2021528451A5 (https=) | ||
| JP2024543013A5 (https=) | ||
| JP2023533037A5 (https=) | ||
| JP2022545158A5 (https=) | ||
| JP2023537410A5 (https=) | ||
| JP2021520394A5 (https=) | ||
| JP2022522890A5 (https=) | ||
| JPS60208975A (ja) | 血小板活性化因子拮抗剤である新規２，５−ジアリ−ルテトラヒドロチオフエン類及びその類縁体 | |
| JP2022537350A5 (https=) |